Abstract
The uncontrolled growth of cells is characteristic of a group of diseases known as cancer. The major difficulty in coping with this problem is that there is, as yet, little information of particular significance on the biochemical differences between normal and malignant tissues. Out of necessity, the chemotherapeutic approach to oncology has been rather empirical with the major successes being noted with drugs which are generally more toxic to rapidly proliferating cells. Most of these cytotoxic anticancer agents act primarily as inhibitors of nucleic acid synthesis at various sites and by different mechanisms.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abraham, D.J., Coohran, T.C, Rosenstein, R.D.: Single-crystal X-ray structures of chemotherapeutic agents. V. The structures of 5-diazo-6-methoxy-6-hydrouracil and 2′-deoxy-5-diazo-6-hydro-O 6, 5′-cyclouridine hemihydrate. J. Amer. chem. Soc. 93, 6279–6281 (1971).
Ansfield, F.J., Ramirez, G.: Phase I and II studies of 2′-deoxy-5-(trifluoromethyl) uridine (NSC-75520). Cancer Chemother. Rep. 55, 205–208 (1971) and references cited therein.
Asbun, W., Binkley, S.B.: Synthesis of 5-substituted pyrimidines. J. org. Chem. 31, 2215–2219 (1966).
Asbun, W., Binkley, S.B.: Synthesis of 5-substituted pyrimidines. II. J. org. Chem. 33, 140–142 1968).
Baltimore, D.: RNΑ-dependent DNΑ-polymerase in virions of RNA tumour viruses. Nature (Lond.) 226, 1209–1211 (1970).
Beardmore, T.D., Kelley, W.N.: Mechanism of allopurinol-mediated inhibition of pyrimidine biosynthesis. J. Lab. clin. Med. 78, 696–704 (1971).
Bergmann, W., Burke, D.C.: Contributions to the study of marine products. XXXIX. The nucleosides of sponges. III. Spongothymidine and spongouridine. J. org. Chem. 20, 1501–1507 (1955).
Birkoper, L., Ritter, A., Kuhlthau, H.P.: Alkylierungen und Glykosidierungen über Silyl-Derivate. Chem. Ber. 97, 934–945 (1964).
Blank, H.U., Fox, J. J.: Pyrimidines VII. A simple conversion of 2-oxo-5-nitro heterocycles to v-triazolo derivatives by sodium azide. J. Amer. chem. Soc. 90, 7175–7176 (1968).
Bloch, A., Dutsohman, G., Grindey, G.: Nucleoside hormone interaction: toxicity of 3-deazauridine in male vs. female mice, as affected by androgens and estrogens. Proc. Amer. Ass. Cancer Res. 13, 19 (1972).
Brown, D.M., Burdon, M.G. Slatcher, R.P.: A synthesis of pseudouridine and of 5-β-d- ribofuranosyluridine. J. chem. Soc. C , 1051–1053 (1968).
Brown, E.G., Silver, A. V.: The natural occurrence of a uracil 5-peptide and its metabolite relationship to guanosine 5′-monophosphate. Biochim. biophys. Acta (Amst.) 119, 1–10 (1966).
Bruemmer, N.C, Holland, J.F., Sheehe, P.R.: Drug effects on a target metabolic pathway and on mouse tumor growth: azauridine and decarboxylation of orotic acid-7-C14. Cancer Res. 22, 113–119 (1962).
Burchenal, J. H., Adams, H.H., Newell, N.S., Fox, J.J.: Comparative activity of 1-β-d-arabinofuranosyl-5-fluorocytosine and related compounds against transplanted mouse leukemias in vitro and in vivo. Cancer Res. 26, 370–373 (1966).
Camiener, G.W.: Studies of the enzymatic deamination of cytosine arabinoside-III. Substrate requirements and inhibitors of the deaminase of human liver. Biochem. Pharmacol. 16, 1691–1702 (1967).
Camiener, G.W.: Studies on the enzymatic deamination of arα-cytidine-V. Inhibition in vitro and in vivo by tetrahydrouridine and other reduced pyrimidine nucleosides. Biochem. Pharmacol. 17, 1981–1991 (1968).
Camiener, G. W., Smith, C.G.: Studies of the enzymatic deamination of cytosine arabinoside I. Enzyme distribution and species specificity. Biochem. Pharmacol. 14, 1405–1416 (1965).
Carbon, J.A., Hung, Jones, D.S., Jones: A reversible oxidative inactivation of specific transfer RNA species. Proc. nat. Acad. Sci. (Wash.) 53, 979–986 (1965).
Cerutti, P., Ikeda, K., Witkop, B.: The selective photoreduction of uridine in polynucleotides. J. Amer. chem. Soc. 87, 2505–2507 (1965).
Chambers, R.W.: The chemistry of pseudouridine. Progr. nucl. Acid, molec. Biol. 5, 349–398 (1966) and references cited therein.
Cheng, C.C.: Some pyrimidines of biological and medicinal interest, Part I. Progr. med. Chem. 6, 67–134 (1969).
Cheng, C.C., Roth, B.: Some pyrimidines of biological and medicinal interest, Part II. Progr. med. Chem. 7, 285–341 (1970).
Cheng, C.C., Roth, B.: Some pyrimidines of biological and medicinal interest, Part III. Progr. med. Chem. 8, 61–117 (1971).
Chenon, M.-T., Pugmtre, R.J., Grant, D.M., Panzica, R.P., Townsend, L.B.: Carbon-13 NMR Spectra of C-nucleosides showdomycin and β-pseudouridine. J. Heterocyclic Chem., 10, 427–429 (1973).
Chu, M.Y., Fischer, G.A.: Effects of cytosine arabinoside on the cell viability and uptake of deoxypyrimidine nucleosides in L5178Y cells. Biochem. Pharmacol. 17, 741–751 (1968a).
Chu, M. Y., Fischer, G.A.: The incorporation of 3H-cytosine arabinoside and its effect on murine leukemic cells (L5178Y). Biochem. Pharmacol. 17, 753–767 (1968b).
Čihák, A., Šorm, F.: Biochemical effects and metabolic transformations of 5-azacytidine in Escherichia coli. Coll. Czech. Chem. Commun. 30, 2091–2102 (1965).
Cohen, R.M., Wolfenden, R.: Cytidine deaminase from Escherichia coli. Purification, properties and inhibition by the potential transition state analog 3,4,5,6-tetrahydrouridine. J. biol. Chem. 246, 7561–7565 (1971).
Cohn, W.E.: Minor constituents of ribonucleic acids. Fed. Proc. 16, 166 (1957).
Cohn, W. E.: Pseudouridine, a carbon-carbon linked ribonucleoside in ribonucleic acids: isolation, structure, and chemical characteristics. J. biol. Chem. 235, 1488–1489 (1960).
Comb, D.G., Katz, S.: Studies on the biosynthesis and methylation of transfer RNA. J. molec. Biol. 8, 790–800 (1964) and references cited therein.
Currie, B.L., Robins, R.K., Robins, M.J.: The synthesis of 3-deazapyrimidine nucleosides related to uridine and cytidine and their derivatives. J. heterocyclic Chem. 7, 323–329 (1970).
Damodaran, N.P., Jones, G.H., Moffat, J.G.: Synthesis of the basic nucleoside skeleton of the polyoxin complex. J. Amer. chem. Soc. 93, 3812–3813 (1971).
Darnall, K.R., Townsend, L.B., Robins, R.K.: The structure of showdomycin, a novel carbon-linked nucleoside antibiotic related to uridine. Proc. nat. Acad. Sci. (Wash.) 57, 548–553 (1967).
Davis, F.F., Allen, F.W.: Ribonucleic acids from yeast which contain a fifth nucleotide. J. biol. Chem. 227, 907–915 (1957).
Dexter, D.L., Wolberg, W.H., Ansfield, F.J., Helson, L., Heidelberger, C: The clinical pharmacology of 5-trifluoromethyl-2′-deoxyuridine. Cancer Res. 32, 247–253 (1972).
Donohue, J., Trtteblood, K.N.: Base pairing in DNA. J. molec. Biol. 2, 363–371 (1960).
Earl, R.A., Townsend, L.B.: The synthesis of l-(tetrahydro-2-furanyl)-5-fluorouracil (ftorafur) via direct fluorination. J. heterocyclic Chem. 9, 1141–1143 (1972).
Eidinoff, M.L., Knoll, J.E., Marano, B. J., Klein, D.: Pyrimidine studies II. Effect of 5-bromodeoxyuridine and related nucleosides on incorporation of precursors into nucleic acid pyrimidines. Cancer Res. 19, 738–745 (1959).
Elstner, E.F., Suhadolnik, R.J.: Nucleoside antibiotics. Biosynthesis of the maleimide nucleoside antibiotic, showdomycin, by Streptomyces showdoensis. Biochemistry 10, 3608–3614 (1971).
Faloonner, R., Gulland, J.M.: The constitution of the purine nucleosides. Part VIII. Uric acid riboside. J. chem. Soc. 1369–1371 (1939).
Favre, A., Miohelson, A.M., Yaniv, M.: Photochemistry of 4-thiouridine in Escherichia coli transfer RNAval. J. molec. Biol. 58, 367–379 (1971).
Fox, J.J., Falco, E.A., Wempen, I., Pomeroy, D., Dowling, M.D., Suichenal, J.H.: Oral and parenteral activity of 2, 2′-anhydro-1-β-D-arabinofuranosyl-5-fluorocytosine against both intraperitoneal and intracerebrally inoculated mouse leukemia. Cancer Res. 32, 2269–2272 (1972).
Fox, J.J., Kuwada, Y., Watanabe, K. A.: Nucleoside LVI. On the structure of the nucleoside antibiotic gougerotin. Tetrahedron Let. 6029–6032 (1968).
Fox, J.J., van Praag, D., Wempen, I., Doerr, I.L., Cheong, L., Knace, J.E., Edinoff, M.L., Bendioh, A., Brown, G.B.: Thiation of nucleosides. II. Synthesis of 5-methyl-2′-deoxycytidine and related pyrimidine nucleosides. J. Amer. chem. Soc. 81, 178–187 (1959).
Furth, J.J., Cohen, S.S.: Inhibition of mammalian DNA polymerase by the 5′-triphosphate of l-β-D-arabinofuranosylcytosine and the 5′-triphosphate of 9-β-D-arabinofuranosyl-adenine. Cancer Res. 28, 2061–2067 (1968).
Gerzon, K., Williams, R.H., Hoehn, M., Gorman, M., Delong, D.C: Pyrazomycin, a C-nucleoside with antiviral activity. 2nd int. Congr. heterocyclic Chem., Montpellier, France (July 1969), p. 131, Abst. C-30.
Ginsberg, T., Davis, F.F.: The biosynthesis of pseudouridine in ribonucleic acids of Escherichia coli. J. biol. Chem. 243, 6300–6305 (1968).
Gish, D.T., Kelley, R.C, Camiener, G.W., Wechter, W.J.: Nucleic acids. 11. Synthesis of 5′-esters of l-β-D-arabinofuranosylcytosine possessing antileukemic and immunosuppressive activity. J. med. Chem. 14, 1159–1162 (1971).
Gish, D.T., Neil, G.L., Weohter, W.J.: Nucleic acids. 12. Synthesis of the L-enantiomer of l-β-D-arabinofuranosylcytosine and of O 2, O 2′-anhydro-1-β-D-ribofuranosylcytosine. J. med. Chem. 14, 882–883 (1971).
Goldin, A., Wood, H.B., Jr., Engle, R.R.: Relation of structure of purine and pyrimidine nucleosides to antitumor activity. Cancer Chemother. Rep. Part 2, 1, 1–269 (1968).
Goody, R.S., Watanabe, K.A., Fox, J. J.: Nucleoside LXVI. Synthetic studies on nucleoside antibiotics. 4. Synthesis of methyl 4-amino-2,3,4-trideoxy-α-D-enrytho-hex-2-enopyrano-siduronic acid, the carbohydrate moiety of blasticidin S. Tetrahedron Let. 293–296 (1970).
Gray, G.D., Nichol, F.R., Camiener, M.M., Gish, D.T., Kelly, R.C, Weöhter, W.J., Moxley, T.E., Neil, G.L.: Immunosuppressive, antiviral and antitumor activities of cytarabine derivatives. Biochem. Pharmacol. 21, 465–475 (1972).
Hauler, H.I., Claybourn, E.B., Tschang, T.P.: Mitochondrial volume changes induced by the antibiotic showdomycin. Biochem. biophys. Res. Commun. 31, 25–31 (1968).
Handschumacher, R.E.: Azauracil ribonucleoside and ribonucleotides: isolation and chemical synthesis. J. biol. Chem. 235, 764–768 (1960).
Haneishi, T., Okazaki, T., Hata, T., Tamura, C., Nomura, M., Naito, A., Seki, I., Arai, M.: Oxazinomycin, a new carbon-linked nucleoside antibiotic. J. Antibiot. (Tokyo) 24A, 797–799 (1972).
Hanka, L.J., Evans, J.S., Mason, D.J., Dietz, A.: A microbiological production of 5-azacytidine I. Production and biological activity. Antimicrob. Agents Chemother. 619–630 (1966).
Hanze, A.R.: Nucleic acids. IV. The catalytic reduction of pyrimidine nucleosides (human liver deaminase inhibitors). J. Amer. chem. Soc. 89, 6720–6725 (1967).
Hatfield, D., Wyngaarden, J.B.: 3-Ribosylpurines I. Synthesis of (3-ribosyluric acid) 5′-phosphate and(3-ribosylxanthine) 5′-phosphate by a pyrimidine ribonucleotide pyrophosphorylase of beef erythrocytes. J. biol. Chem. 239, 2580–2586 (1964a).
Hatfield, D., Wyngaarden, J.B.: 3-Ribosylpurines II. Studies on 3-ribosylxanthine-5′-phosphate and on ribonucleotide derivatives of certain uracil analogues. J. biol. Chem. 239, 2587–2592 (1964b).
Heidelberger, C., Parsons, D.G., Remy, D.C: Synthesis of 5-trifluoromethyl-2′-deoxyuridine. J. med. Chem. 7, 1–5 (1964).
Hernandez, K., Pinkel, D., Lee, S., Leone, L.: Chemotherapy with 6-azauridine (NSC-32074) for patients with leukemia. Cancer Chemother. Rep. 53, 203–207 (1969).
Hiller, S.A., Zhuk, R.A., Lidaks, M.Y.: Analogs of pyrimidine nucleosides I. N1(α-furanyl) derivatives of pyrimidine bases as antimetabolites. Dokil. Akad. Nauk. (USSR) 176, 332–335 (1967).
Hiller, S.A., Lidaks, M.Y., Zhuk, R.A., Pets, K.I., Getsova, I.N., Berzinya, A.E.: Analogues of pyrimidine nucleosides in chemotherapy of cancer. First All-Union Conference on Chemotherapy of Malignant Tumors, Riga, USSR, 7–11 October 1968, p. 111.
Ho, N.W.H., Gilham, P.T.: Reaction of pseudouridine and inosine with N-cyclohexyl-N-β (4-methylmorpholinium)ethylcarbodiimide. Biochemistry 10, 3651–3657 (1971), and references cited therein.
Hoffman, J.L., McConnell, K.P., Carpenter, D.R.: Aminoacylation of Escherichia coli methionine t-RNA by selenomethionine. Biochim. biophys. Acta (Amst.) 199, 531–534 (1970).
Holland, J.F., Korn, R., O’Malley, J., Minnemeyer, H. J., and Tieckelmann, H.: 5-Allyl-2′-deoxyuridine, inhibition of nucleoside Phosphorylase in Hela cells containing mycoplasma. Cancer Res. 27, 1867 (1967).
Hori, M., Kakiki, K., Suzuki, S., Misato, T.: Studies on the mode of action of polyoxins, Part III. T.: Studies on the mode of action of polyoxins, Part III. Relation of polyoxin structure to chitin synthetase inhibition. Agr. biol. Chem. (Tokyo) 35, 1280–1291 (1971).
Hoshi, A., Kanzawa, F., Kuretani, K., Saneyoshi, M., Arai, Y.: 2,2′-O-Cyclocytidine, an antitumor cytidine analog resistant to cytidine deaminase. Gann 62, 145–146 (1971).
Hoshi, A., Kanazawa, F., Kuretani: Antitumor activity of cyclocytidine in a variety of tumors. Gann. 63, 353–360 (1972).
Howard, J.P., Cevik, N., Murphy, M.L.: Cytosine arabinoside (NSC-63878) in acute leukemia in children. Cancer Chemother. Rep. 50, 287–291 (1966).
Hrodek, O., Vesely, J.: 5-Azacytidine in childhood leukemia. Neoplasma (Bratisl.) 18, 493–503 (1971), and references cited therein.
Hruska, F.E.: Molecular conformation of orotidine, a naturally occurring nucleoside, in the syn conformation in aqueous solution. J. Amer. chem. Soc. 93, 1795–1797 (1971).
Hruska, F.E.: Long-range spin-spin coupling in pyrimidine nucleosides. Canad. J. Chem. 49, 2111–2118 (1971).
Iida, S., Hayatsu, H.: Chemical transformation of 4-thiouridine with nitrous acid. Biochem. biophys. Res. Commun. 43, 163–167 (1971).
Isono, K., Asaki, K., Suzuki, S.: Studies on polyoxins, antifungal antibiotics. XIII. The structure of polyoxins. J. Amer. chem. Soc. 91, 7490–7505 (1969), and references cited therein.
Isono, K., Chain, P.F., Odiorne, T.J., McCloskey, J.A., Suhadolntk, R.J.: Biosynthesis of the 5-fluoropolyoxins, aberrant nucleoside antibiotics. J. Amer. Chem. Soc. 95, 5788–5789 (1973).
Isono, K., Suzuki, S., Azumo, T.: Semisynthetic polyoxins; aminoacyl derivatives of polyoxin C and their in vitro activity. Agr. biol. Chem. (Tokyo) 35, 1986–1989 (1971).
Ivanovics, G.A., Rousseau, R. J., Robins, R.K.: Nucleoside peptides. 2. Synthesis of certain 5-N-aminoacyl and 5-N-peptidyl derivatives of 5-aminouridine. J. med. Chem. 14, 1155–1158 (1971).
Jones, M.E.: Regulation of pyrimidine and arginine biosynthesis in mammals, in Advances in Enzyme Regulation. Vol. 9. pp. 19–49. George Weber, (Ed)., New York: Pergamon Press 1971.
Kalman, T.L: Enzymatic synthesis of 2′-deoxy-pseudouridylic acid. Biochem. biophys. Res. Commun. 46, 1194–1200 (1972).
Kalman, T.L, Bardos, T.J.: Enzymatic studies relating to the mode of action of 5-mercapto-2,-deoxyuridine. Molec. Pharmacol. 6, 621–630 (1970).
Kalvoda, L., Farkaš, J., Šorm, F.: Synthesis of showdomycin. Tetrahedron Let. 2297–2300 (1970).
Kanai, T., Kojima, T., Maruyama, O., Ichino, M.: Pyrimidine nucleosides III. Reaction of cytidine or N 4-acetylcytidine with partially hydrolyzed phosphorus oxychloride. Chem. pharm. Bull. (Tokyo) 18, 2569–2571 (1970).
Kanzaki, T., Higashide, E., Yamamoto, H., Shibata, M., Nakazawa, K., Iwasaki, H., Takewaka, T., Miyake, A.: Gougerotin, a new antibacterial antibiotic. J. Antibiot. (Tokyo) 15 A, 93–97(1962).
Kapuler, A.M., Reich, E.: Some stereochemical requirements of Escherichia coli ribonucleic acid polymerase interaction with conformationally restricted ribonucleoside 5′-triphosphates: 8-bromoguanosine, 8-ketoguanosine, and 6-methylcytidine triphosphates. Biochemistry 10, 4050–4061 (1971).
Karon, M., Shtrakawa, S.: The locus of action of l-β-D-arabinofuranosylcytosine in cell cycle. Cancer Res. 29, 687–696 (1969).
Kelley, W.N., Fox, I. H., Beardmore, T.D., Meade, J.C: Allopurinol and oxipurinol: alteration of purine and pyrimidine metabolism in cell culture. Aim. N. Y. Acad. Sci. 179, 588–595 (1971).
Kikugawa, K., Ichino, M.: Studies on the Vilsmeir-Haack reaction. IV. Convenient synthesis of 2, 2′-anhydro-1-β-D-arabinofuranosylcytosine (2, 2′-cyclocytidine) and its derivatives. J. org. Chem. 37, 284–288 (1972).
Komatsu, Y.: Mechanism of action of showdomycin, Part IV. Interactions between the mechanisms for transport of showdomycin and of various nucleosides. Agr. biol. Chem. (Tokyo) 35, 1328–1339 (1971).
Komatsu, Y., Tanaka, K.: Mechanism of action of showdomycin, Part II. Effect of show-domycin on the synthesis of deoxyribonucleic acid in Escherichia coli. Agr. biol. Chem. (Tokyo) 34, 891–899 (1970).
Kondo, T., Goto, T.: Synthesis of l-(4-amino-4-deoxy-β-D-glucopyranosyl)uracil. Agr. biol. Chem. (Tokyo) 35, 625–628 (1971).
Kondo, T., Naki, H., Goto, T.: Synthesis of cytosine, the nucleoside component of the antibiotic blasticidin S. Tetrahedron Let. 1881–1884 (1972).
Kotiok, M., Szantay, C., Bardos, T.J.: Synthesis of 5-S-substituted 2/-deoxyuridines. Study of the factors influencing the stereo-selectivity of the silyl modification of the Hilbert-Johnson reaction. J. org. Chem. 34, 3806–3822 (1969).
Kowollik, G., Gaertner, K., Etzold, G., Langen, P.: Nucleoside von Fluor-Zuckern, Teil III. Synthese 5′-fluorsubstituierter Desoxyribonucleoside. Carbohydrate Kes. 12, 301–311 (1970a).
Kowollik, G., Gaertner, K., Langen, P.: Nucleoside von Fluor-Zuckern; Synthese neuer potentieller DNS-Hemmstoffe. Z. Chem. 10, 141–142 (1970b).
Kravohenko, I.M., Zidermane, A.A.: Antineoplastic activity of fluorafur [N3-(2′-furanidyl)-5-fluorouracil] in experiment. First All-Union Conference on Chemotherapy of Malignant Tumors, Riga, USSR, 7–11 October 1968 p. 214–215.
Kumura-Harada, F., Saneyoshi, M., Nishimura, S.: 5-Methyl-2-thiouridine: a new sulfur-containing minor constituent from rat liver glutamic acid and lysine t-RN As. Febs Letters, 13, 335–338 (1971).
Kusakabe, Y., Nogatsu, J., Shibuya, M., Kawaguchi, O., Hirose, C., Shirato, S.: Minimycin, a new antibiotic. J. Antibiot. (Tokyo) 25A, 44–47 (1972).
Lane, B.G.: The alkali-stable trinucleotide sequences and the chain termini in 18S and 28S ribonucleates from wheat germ. Biochemistry 4, 212–219 (1965).
Langen, P., Kowollik, G., Schutt, M., Etzold, G.: Thymidylate kinase as target enzyme for 5′-deoxythymidine and various 5′-deoxy-5′-halogeno pyrimidine nucleosides. Acta biol. Med. germ. 23, K 19–22 (1969).
Leich, U., Burdon, M.G., Moffat, J.G.: C-Glycosyl nucleosides. I. Studies on the synthesis of pseudouridine and related compounds. J. org. Chem. 36, 1507–1513 (1971).
Lieu, T.S., Hudson, R.A., Brown, R-K., White, B.C.: Transport of pyrimidine nucleosides across human erythrocyte membranes. (Amst.) 241, 884–893 (1971).
Lindsay, R.H., Tillery, C.R., Wong Yu, M.Y.: Conversion of the antithyroid drug 2-thiouracil to 2-thio-5′-UMP by UMP pyrophosphorylase. Arch. Biochem. Biophys. 148, 466–474 (1972).
Lipsett, M.N.: The isolation of 4-thiouridylic acid from the soluble ribonucleic acid of Escherichia coli. J. biol. Chem. 240, 3975–3978 (1965).
Lohrmann, R., Lagowski, J.M., Forrest, H.S.: 3-Ribosyluric acid. Part III. Unambiguous syntheses of 3-ribosyluric acid and related compounds. J. Chem. Soc. 451–459 (1964).
Lozzio, C.B., Wigler, P.W.: Cytotoxic effects of thiopyrimidines. J. cell. Physiol. 78, 25–32 (1971).
Maryanka, D., Johnston, I.R.: The inhibition of DNA-dependent RNA polymerase of E. coli by showdomycin. Febs Let. 7, 125–128 (1970).
Matsushita, S., Fanburg, B.L.: Pyrimidine nucleotide synthesis in the normal and hyper-trophying rat heart, relative importance of the de novo and salvage pathways. Circulation Res. 27, 415–428 (1970).
Michelson, A.M., Cohn, W.E.: Cyclo-pseudouridine and the configuration of pseudouridine. Biochemistry 1, 490–495 (1962).
Miles, D.W., Robins, M.J., Robins, R.K., Winkley, M.W., Eyring, H.: Circular dichroism of nucleoside derivatives IV. Uracil derivatives. J. Amer. chem. Soc. 91, 824–831 (1969).
Milne, G.H., Townsend, L.B.: The synthesis of α- and β-2′-deoxyselenoguanosine. Biochim. Biophys. Acta 269, 344–346 (1972).
Milne, G.H., Townsend, L.B.: Purine nucleosides XXXII, synthesis and reactivity of 6-alkylseleno-9-(β-D-ribofuranosyl)purines. J. Chem. Soc. Perk. Trans I, 313–315 (1973).
Minnemeyer, H.J., Tieckelman, H., Holland, J.F.: 5-Allyluridine. J. med. Chem. 6, 602 (1963).
Moravek, J., Škoda, J.: Biochemically important labelled compounds. IV. Biosynthetic preparation of 6-azauridine [4, 5-14C] and its isolation by gel filtration. Coll. Czech. Chem. Commun. 34, 1837–1840 (1969).
Nakagawa, Y., Kano, H., Tsukuda, Y., Koyama, H.: Structure of a new class of C-nucleoside antibiotic, showdomycin. Tetrahedron Let. 4105–4109 (1967).
Nedl, G.L., Wiley, P.F., Manak, R.C, Moxley, T.E.: Antitumor effect of l-β-D-arabino- furanosylcytosine 5′-adamantoate (NSC 117614) in L1210 leukemic mice. Cancer Res. 30, 1047–1054 (1970).
Nishimttra, H., Mayama, M., Komatsit, Y., Kato, H., Shimaoka, N., Tanaka, T.: Showdomycin, a new antibiotic from a Streptomyces sp. J. Antibiot. (Tokyo) 17 A, 148–155 (1964).
Nodinski, L., Kensler, C.J.: Activity of cytosine arabinoside (NSC 117614) in L1210 leukemic mice. Cancer Chemother. Rep. 47, 65–68 (1965).
Noell, C.W., Cheng, C.C.: Pyrimidines XVII. l-(Tetrahydro-2-pyranyl) cytosine, -uracil, -thymine. J. heterocyclic Chem., 3, 5–8 (1966).
Noell, C.W., Cheng, C.C.: Pyrimidines XXI. l-(Tetrahydro-2-furyl)-pyrimidines. J. hetero-cyclic Chem. 5, 25–28 (1968).
Ohrui, H., Kuztthara, H., Emato, S.: Synthesis of deoxypolyoxin C, thymine polyoxin C. Tetrahedron Let. 4267–4270 (1971).
Oliver, J. M., Paterson, A.R.P.: Nucleoside transport I. A mediated process in human erythrocytes. Canad. J. Biochem. 49, 262–270 (1970).
Panzica, R.P., Robins, R.K., Townsend, L.B.: Synthesis and anticancer activity of cytosine arabinoside 3-N-oxide (arα-C 3-N-oxide). J. med. Chem. 14, 259 (1971).
Paterson, A.R.P., Oliver, J.M.: Nucleoside transport II. Inhibition of p-nitrobenzylthioguanosine and related compounds. Canad. J. Biochem. 49, 271–274 (1971).
Phillips, G.R.: Primary structure of transfer RNA. Nature (Lond.) 223, 374–377 (1969).
PÃskala, A., Å orm, F.: Nucleic acid components and their analogues. LI. Synthesis of 1-glycosyl derivatives of 5-azauracil and 5-azacytosine. Coll. Czech. Chem. Commun. 29, 2060–2076 (1964).
Pleiss, M.G., Cerutti, P.A.: Phototransformation of 4-thiouridine in Escherichia coli valine transfer ribonucleic acid to uridine, cytidine and N 4-methylcytidine. Biochemistry 10, 3093–3099 (1971).
Pontis, H., Degersted UG., Reiohard, P.: Uridine and deoxyuridine phosphorylases from Ehrlich ascites tumor. Biochim. biophys. Acta (Amst.) 51, 138–147 (1961).
Prystaš, M., Šorm, F.: Nucleic acid components and their analogues. XXII. Synthesis of 6-azauridine and ö-methyl-6-azauridine. Coll. Czech. Chem. Commun. 27, 1578–1584 (1962).
Prystaš, M., Šorm, F.: Synthesis of 6-methyl- and 5, 6-dimethyluridines and cytidines. Coll. Czech. Chem. Commun. 33, 331–335 (1968).
Prystaš, M., Šorm, F.: Nucleic acid components and their analogues. CXXVII. Synthesis of uridine and cytidine 6-methyl and 5, 6-dimethyl derivatives. Coll. Czech. Chem. Commun. 34, 2316–2347 (1969).
Reid, T.W., Albert, D.M.: RNΑ-dependent DNΑ-polymerase activity in human tumors. Biochem. biophys. Res. Commun. 46, 383–389 (1972).
Roberts, M., Visser, D.W.: Antimetabolite activity of uridine and cytidine derivatives. J. biol. Chem. 194, 695–701 (1952).
Robins, M.J., Currie, B.L., Robins, R.K., Bloch, A.: The biological activity of 3-deaza-pyrimidine nucleosides. Proc. Amer. Ass. Cancer Res. 10, 73 (1969).
Robins, R.K.: Synthesis of some 4, 6-substituted pyrazolo [3, 4-d]pyrimidines. J. Amer. chem. Soc. 78, 784–790 (1956).
Rogers, G.T., Ulbricht, T.L.V.: Optical rotatory studies on nucleic acid derivatives, 3-transitions and the relation of the B 2U cotton effect of conformation in pyrimidine and azapyrimidine nucleosides. Europ. J. Biochem. 22, 457–466 (1971), and references cited therein.
Roy-Burman, S., Roy-Burman,P., Visser, D.W.: Showdomycin, a new nucleoside antibiotic. Cancer Res. 28, 1605–1610 (1968).
Saenger, W., Scheit, K.H.: A pyrimidine nucleoside in the syn conformation: molecular and crystal structure of 4-thiouridine hydrate. J. molec. Biol. 50, 153–169 (1970).
Sasaki, K., Kusakabe, Y., Esumi, S.: The structure of minimycin, a novel carbon-linked nucleoside antibiotic related to β-pseudouridine. J. Antibiot. (Tokyo) 25 A, 152–154 (1972).
Saslaw, L.D., Grindey, G.B., Kline, I., Waravdeear, V.S.: Sparing action of uridine on the activity of arabinosylcytosine with normal and leukemic mice. Cancer Res. 28, 11–20 (1968).
Sato, E., Kanaoka, Y.: Photoreduction of 4- and 2-thiouracil and 4-thiouridine. Tetrahedron Let. 3547–3548 (1969).
Schmidt, C.L., Rijsho, W.J., Townsend, L.B.: The synthesis of bicyclic nucleosides related to uridine, 4-(β-D-ribofuranosyl)thiazolo[5, 4-d]pyrimidines. Chem. Commun. 1515–1516 (1971).
Schmidt, C.L., Townsend, L.B.: The synthesis of bicyclic nucleosides related to cytidine; 3-(β-D-ribofuranosyl)isoguanine. J. Heterocyclic Chem. 10, 687–688 (1973).
Schrecker, A.W., Urshel, M.J.: Metabolism of 1-β-D-arabinofuranosylcytosine in leukemia L1210: studies with intact cells. Cancer Res. 28, 793–801 (1968).
Schuster, G.S., Hare, J.D.: The role of phosphorylation in the uptake of thymidine in mammalian cells. In Vitro 6, 427–436 (1971).
Schwartz, S.H., Bardos, T.J., Burgess, G.H., Klein, E.: Cytostatic and immunologic activity of 5-mercaptouracil deoxyriboside in the management of multiple superficial basal cell epitheliomas. J. Med. 1, 174–179 (1970).
Schweizer, M.P., Witowski, J.T., Robins, R.K.: Nuclear magnetic resonance determination of syn and anti conformations in pyrimidine nucleosides. J. Amer. chem. Soc. 93, 277–279 (1971).
Shapiro, R., Chambers, R.W.: Synthesis of Pseudouridine. J. Amer. chem. Soc. 83, 3920–3921 (1961).
Shen, T.Y., McPherson, J.F., Linn, B.O.: Nucleosides III. Studies on 5-methylamino-2′-deoxyuridine as a specific antiherpes agent. J. med. Chem. 9, 366–369 (1966).
Shimuzu, B., Asai, M., Hieder, H., Miyaki, M., Okazaki, H.: Preparation of L-β-ribo-nucleotides. Chem. pharm. Bull. (Tokyo) 13, 616–618 (1965).
Shoaf, W.T., Jones, M.E.: Initial steps in pyrimidine synthesis in Ehrlich ascites carcinoma. Biochem. biophys. Res. Commun. 45, 796–802 (1971).
Shugart, L.: Effect of selective chemical modification of 4-thiouridine of phenylalanine transfer ribonucleic acid on enzyme recognition. Arch. Biochem. Biophys. 148, 488–495 (1972).
Sköld, O.: Uridine kinase from Ehrlich ascites tumor: purification and properties. J. biol. Chem. 235, 3273–3279 (1960).
SlavÃk, M., Keiser, H.R., Lovenberg, W., Sjöerdsma, A.: Hyperaminoacidemia in rabbits treated with 6-azauridine triacetate. Life Sci. 10, 1293–1295 (1971).
Smith, D.A., Roy-Burman, P., Visser, D.W.: Studies of 5-aminouridine. Biochim. biophys. Acta (Amst.) 119, 221–228 (1966).
Suok, D., Saenger, W., Vorbruggen, H.: Conformation of 6-methyl-uridine — a pyrimidine nucleoside in the syn conformation. Nature (Lond.) 235, 333–334 (1972).
Suhadolnik, R. J.: Nucleoside antibiotics, pp. 172–202. New York: Wiley-Interscience 1970.
Sweeny, M.J., Gtttowski, G.E., Poore, G.A., Hamill, R.L.: Pyrazomycin: a new antitumor antibiotic. Proc. Amer. Ass. Cancer Res. 13, 108 (1972).
Takeuchi, S., Hirayama, K., Ueda, K., Sakai, H., Yonehara, H.: Blasticidin S, a new antibiotic. J. Antibiot. (Tokyo) 11A, 1–5 (1958).
Tarr, H.L.A., Roy, J.E., Yamamoto, M.: Fish liver pyrimidine deoxynucleoside Phosphorylase and deoxyribosyltransferase. Canad. J. Biochem. 46, 407–415 (1968).
Temin, H. M., Mitzutani, S.: RNA-dependent DNA polymerase in virions of Rous sarcoma virus. Nature (Lond.) 226, 1211–1213 (1970).
Thiry, L.: Viruses grown in the presence of base analogs. Specific alteration of susceptibility to inactivation by radiation, mutagens, and protodyes. Virology 28, 543–554 (1966).
Thomson, M.J., Garland, M.R., Richards, J.F.: Metabolic effects of nucleosides in rat thymus cells in vitro. J. cell. Physiol. 77, 17–30 (1971).
Thurber, T.C, Townsed L.B.: A structural study of 5-diazouracil, 5-diazouridine, and 5-diazo-2′-deoxyuridine by PMB spectroscopy and a discussion of certain reactions in view of the revised structures. 3rd Intern. Cong. Heterocyclic Chem., Sendai, Japan, August 1971.
Tolman, R.L., Robins, R.K.: Synthesis of 1-β-1-arabinofuranosylcytosine the enantiomer of cytosine arabinoside. J. med. Chem. 14, 1112 (1972).
Townsend, L.B.: Selection of specific compounds with potential antitumor activity for synthesis on the basis of screening data. 2nd Annual NCI Contractors meeting, Annapolis, Maryland, 3–5 November, 1971.
Townsend, L.B.: Unpublished testing data received from NCI for XVII and XVIII against leukemia L1210, 1972a.
Townsend, L.B.: Synthetic procedures in nucleic acid chemistry, vol. II, Chapt. 7. W. W. Zorbach and R. S. Tipson (Eds.) New York: Intersience 1972b.
Townsend, L.B., Milne, G.H.: Synthesis of the selenium congener of the naturally occurring guanosine nucleoside, 6-selenoguanosine. J. Heterocyclic Chem. 7, 753–754 (1970).
Townsend, L.B., Robins, R.K.: Nucleoside antibiotics. Physicochemical constants, spectral, chemotherapeutic and biological properties. In: Sober(Ed.): Handbook of Biochemistry and Molecular Biology pp. G115–G213.2ed. Cleveland, Ohio: The Chemical Rubber Co. 1970.
Townsend, L.B., Patil, V.D., Bloch, A.: Synthesis and biological activity of ribofuranosyl derivatives of oxazolo[5, 4-d]pyrimidines. Proc. Amer. Ass. Cancer Res. 12, 74 (1971).
Trimble, R.B., Maley, F.: Metabolism of 4-N-hydroxycytidine in Escherichia coli. J. Bact. 145–153 (1971).
Tsukuda, Y., Koyama, H.: Crystal and Molecular Structure of Showdomycin. J. chem. Soc. 1709–1712 (1970).
Uchida, K., Kreis, W.: Studies on drug resistance — I. Distribution of 1-β-D-arabinofuranosyl-cytosine, cytidine and deoxycytidine in mice bearing ara-C sensitive and resistant P815 neoplasms. Biochem. Pharmacol. 18, 1115–1127 (1969).
Ueda, T., Iida, Y., Ikeda,K., Mizuno, Y.: Synthesis of 2,4-dithiouridine and 2-thiocytidines. Chem. pharm. Bull. (Tokyo) 16, 1788–1794 (1968), and references cited therein.
Visser, D.W.: Antimetabolites and cancer, p. 47. C. P. Rhoads (Ed.). Washington, D. C: Amer. Assoc, for the Adv. of Sci. 1955.
Walwich, E.R., Dekker, C.A., Roberts, W.K.: Cyclisation during the phosphorylation of uridine and cytidine by polyphosphoric acid: a new route to the O 2, 2′-eyclonucleosides. Proc. chem. Soc. 84 (1959).
Wang, M.C, Bloch, A.: Studies on the mode of action of 3-deazapyrimidines. Biochem. Pharmacol. 21, 1063–1073 (1972).
Watanabe, K.A., Kotick, M.P., Fox, J. J.: Nucleosides LXIII. Synthetic studies on nucleo-side antibiotics. 3. Total synthesis of 1-(4-amino-4-deoxy-β-D-glucopyranosyluronic acid)-cytosine, the nucleoside moiety of gougerotin. J. org. Chem. 35, 231–236 (1970).
Watanabe, K.A., Falco, E.A., Fox, J. J.: Total synthesis of gougerotin. J. Amer. chem. Soc. 94, 3272–3274 (1972a).
Watanabe, K.A., Wempen, I.M., Fox, J.J.: Nucleosides Part LXXII. Synthetic studies on nucleoside antibiotics. 7. An improved synthesis of C-substance. Carbohydrate Res. 21, 148–153 (1972 b), and references cited therein.
Watanabe, S.: Equimolecular reaction of showdomycin with thiols. J. Antibiot. 23 A, 313–314 (1970).
Wiley, P.F., Maokeller, F.A.: The structure of sparsomycin. J. Amer. chem. Soc. 92 417–418 (1970).
Williams, R.H., Gerzon, K., Hoehn, M., Gorman,M., Delong,D.C: Pyrazomycin — a novel carbon-linked nucleoside. 158th Nat. Amer. Chem. Soc. Meeting, September 1969, New York: MICR 038.
Winkley, M. W., Robins, R.K.: Pyrimidine nucleosides I. The synthesis of 6-methylcytidine, 6-methyluridine, and related 6-methylpyrimidine nucleosides. J. org. Chem. 33, 2822–2827 (1968).
Winkley, M.W., Robins, R.K.: Direct glycosylation of 1,3,5-triazinones. A new approach to the synthesis of the nucleoside antibiotic 5-azacytidine (4-amino-1-β-D-ribofuranosyl-1,3,5-triazin-2-one) and related derivatives. J. org. Chem. 35, 491–495 (1970).
Wise, D.S., Townsend, L.B.: Synthesis of the selenopyrimidine nucleosides 2-seleno and 4-selenouridine. J. Heterocyclic Chem. 10, 1461–1462 (1972).
Yamaoka, N., Otter, B.A., Fox, J.J.: Nucleosides. XLV. 1-α-1-aldopentofuranosylpyrimidines. J. med. Chem. 11, 55–59 (1968).
Yaniv, M., Chestier, A., Gros, A., Favre, A.: Biological activity of irradiated tRNAval containing a 4-thiouridine-cytosine dimer. J. molec. Biol. 58, 381–388 (1971).
Yonehara, H., Otake, N.: Absolute configuration of Blasticidin S. Tetrahedron Let. 3785–3791 (1966).
Zachau, H.G.: Transfer ribonucleic acids. Angew. Chem. 8, Int. Ed. 711–727 (1969).
Zimmerman, M.: Deoxyribosyl transfer, III. Catalysis of 3-pentosylpurine formation by pyrimidine nucleoside phosphorylases. J. biol. Chem. 241, 4914–4916 (1966).
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1974 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Townsend, L.B., Cheng, C.C. (1974). Rational Design of Pyrimidine Nucleoside Analogs. In: Sartorelli, A.C., Johns, D.G. (eds) Antineoplastic and Immunosuppressive Agents Part I. Handbuch der experimentellen Pharmakologie / Handbook of Experimental Pharmacology, vol 38 / 1. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-65678-1_6
Download citation
DOI: https://doi.org/10.1007/978-3-642-65678-1_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-65680-4
Online ISBN: 978-3-642-65678-1
eBook Packages: Springer Book Archive